Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies

Tunneling nanotubes (TNTs) are thin membrane elongations among the cells that mediate the trafficking of subcellular organelles, biomolecules, and cues. Mesenchymal stem cells (MSCs) receive substantial attention in tissue engineering and regenerative medicine. Many MSCs-based clinical trials are on...

Full description

Bibliographic Details
Main Authors: Thangavelu Soundara Rajan, Agnese Gugliandolo, Placido Bramanti, Emanuela Mazzon
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/10/3481
_version_ 1797567958992551936
author Thangavelu Soundara Rajan
Agnese Gugliandolo
Placido Bramanti
Emanuela Mazzon
author_facet Thangavelu Soundara Rajan
Agnese Gugliandolo
Placido Bramanti
Emanuela Mazzon
author_sort Thangavelu Soundara Rajan
collection DOAJ
description Tunneling nanotubes (TNTs) are thin membrane elongations among the cells that mediate the trafficking of subcellular organelles, biomolecules, and cues. Mesenchymal stem cells (MSCs) receive substantial attention in tissue engineering and regenerative medicine. Many MSCs-based clinical trials are ongoing for dreadful diseases including cancer and neurodegenerative diseases. Mitochondrial trafficking through TNTs is one of the mechanisms used by MSCs to repair tissue damage and to promote tissue regeneration. Preclinical studies linked with ischemia, oxidative stress, mitochondrial damage, inflammation, and respiratory illness have demonstrated the therapeutic efficacy of MSCs via TNTs-mediated transfer of mitochondria and other molecules into the injured cells. On the other hand, MSCs-based cancer studies showed that TNTs may modulate chemoresistance in tumor cells as a result of mitochondrial trafficking. In the present review, we discuss the role of TNTs from preclinical studies associated with MSCs treatment. We discuss the impact of TNTs formation between MSCs and cancer cells and emphasize to study the importance of TNTs-mediated MSCs protection in disease models.
first_indexed 2024-03-10T19:49:35Z
format Article
id doaj.art-5e295cadaf6d46e38250042b98f4e0a4
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T19:49:35Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-5e295cadaf6d46e38250042b98f4e0a42023-11-20T00:31:05ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-05-012110348110.3390/ijms21103481Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical StudiesThangavelu Soundara Rajan0Agnese Gugliandolo1Placido Bramanti2Emanuela Mazzon3Department of Biotechnology, School of Life Sciences, Karpagam Academy of Higher Education, Coimbatore 641021, IndiaIRCCS Centro Neurolesi “Bonino-Pulejo”, Via Palermo, Contrada Casazza S.S.113, 98124 Messina, ItalyIRCCS Centro Neurolesi “Bonino-Pulejo”, Via Palermo, Contrada Casazza S.S.113, 98124 Messina, ItalyIRCCS Centro Neurolesi “Bonino-Pulejo”, Via Palermo, Contrada Casazza S.S.113, 98124 Messina, ItalyTunneling nanotubes (TNTs) are thin membrane elongations among the cells that mediate the trafficking of subcellular organelles, biomolecules, and cues. Mesenchymal stem cells (MSCs) receive substantial attention in tissue engineering and regenerative medicine. Many MSCs-based clinical trials are ongoing for dreadful diseases including cancer and neurodegenerative diseases. Mitochondrial trafficking through TNTs is one of the mechanisms used by MSCs to repair tissue damage and to promote tissue regeneration. Preclinical studies linked with ischemia, oxidative stress, mitochondrial damage, inflammation, and respiratory illness have demonstrated the therapeutic efficacy of MSCs via TNTs-mediated transfer of mitochondria and other molecules into the injured cells. On the other hand, MSCs-based cancer studies showed that TNTs may modulate chemoresistance in tumor cells as a result of mitochondrial trafficking. In the present review, we discuss the role of TNTs from preclinical studies associated with MSCs treatment. We discuss the impact of TNTs formation between MSCs and cancer cells and emphasize to study the importance of TNTs-mediated MSCs protection in disease models.https://www.mdpi.com/1422-0067/21/10/3481tunneling nanotubesmesenchymal stem cellsmitochondriacancer cellspreclinical studies
spellingShingle Thangavelu Soundara Rajan
Agnese Gugliandolo
Placido Bramanti
Emanuela Mazzon
Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies
International Journal of Molecular Sciences
tunneling nanotubes
mesenchymal stem cells
mitochondria
cancer cells
preclinical studies
title Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies
title_full Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies
title_fullStr Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies
title_full_unstemmed Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies
title_short Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies
title_sort tunneling nanotubes mediated protection of mesenchymal stem cells an update from preclinical studies
topic tunneling nanotubes
mesenchymal stem cells
mitochondria
cancer cells
preclinical studies
url https://www.mdpi.com/1422-0067/21/10/3481
work_keys_str_mv AT thangavelusoundararajan tunnelingnanotubesmediatedprotectionofmesenchymalstemcellsanupdatefrompreclinicalstudies
AT agnesegugliandolo tunnelingnanotubesmediatedprotectionofmesenchymalstemcellsanupdatefrompreclinicalstudies
AT placidobramanti tunnelingnanotubesmediatedprotectionofmesenchymalstemcellsanupdatefrompreclinicalstudies
AT emanuelamazzon tunnelingnanotubesmediatedprotectionofmesenchymalstemcellsanupdatefrompreclinicalstudies